| Alteration in copy numbers of genes as a mechanism for acquired drug resistance K Yasui, S Mihara, C Zhao, H Okamoto, F Saito-Ohara, A Tomida, ... Cancer research 64 (4), 1403-1410, 2004 | 275 | 2004 |
| TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas K Yasui, S Arii, C Zhao, I Imoto, M Ueda, H Nagai, M Emi, J Inazawa Hepatology 35 (6), 1476-1484, 2002 | 189 | 2002 |
| PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas H Okamoto, K Yasui, C Zhao, S Arii, J Inazawa Hepatology 38 (5), 1242-1249, 2003 | 141 | 2003 |
| Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis C Zhao, K Yasui, CJ Lee, H Kurioka, Y Hosokawa, T Oka, J Inazawa Cancer 98 (1), 18-23, 2003 | 131 | 2003 |
| Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy S Tanaka, S Arii, M Yasen, K Mogushi, NT Su, C Zhao, I Imoto, Y Eishi, ... British Journal of Surgery 95 (5), 611-619, 2008 | 115 | 2008 |
| POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17 C Zhao, J Inoue, I Imoto, T Otsuki, S Iida, R Ueda, J Inazawa Oncogene 27 (1), 63-75, 2007 | 60 | 2007 |
| Pathway Bridge Based Multiobjective Optimization Approach for Lurking Pathway Prediction XZ Rengjing Zhang, Chen Zhao, Zixiang Xiong Biomed Res Int 2014, 2014 | 12 | 2014 |
| Method for detecting multiple myeloma and method for inhibiting the same C Zhao, J Inoue, I Imoto, J Inazawa US Patent App. 11/902,504, 2007 | 2 | 2007 |
